United States · FDA National Drug Code directory
Halaven
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43624-002_494dbaab-6ded-549d-e063-6394a90a4022
- Product NDC
- 43624-002
- Form
- INJECTION
- Composition / generic term
- eribulin mesylate
- Labeler
- BSP Pharmaceuticals SpA
- Marketing category
- NDA
- Marketing start / end (source format)
- 20170421
- Source listing expiry
- 20271231
Source-listed ingredients
- ERIBULIN MESYLATE — 1 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 100 VIAL in 1 TRAY (43624-002-01) / 2 mL in 1 VIAL · 43624-002-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →